Cargando…
Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review
There is mounting evidence that pulmonary arterial hypertension (PAH), asthma and chronic obstructive pulmonary disease (COPD) share important pathological features, including inflammation, smooth muscle contraction and remodeling. No existing drug provides the combined potential advantages of reduc...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090995/ https://www.ncbi.nlm.nih.gov/pubmed/21477377 http://dx.doi.org/10.1186/1465-9921-12-45 |